Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice

  1. Costanzo, A.
  2. Llamas-Velasco, M.
  3. Fabbrocini, G.
  4. Cuccia, A.
  5. Rivera-Diaz, R.
  6. Gaarn Du Jardin, K.
  7. Kasujee, I.
  8. Puig, L.
  9. Carrascosa, J.M.
Zeitschrift:
Journal of the European Academy of Dermatology and Venereology

ISSN: 1468-3083 0926-9959

Datum der Publikation: 2023

Ausgabe: 37

Nummer: 10

Seiten: 2004-2015

Art: Artikel

DOI: 10.1111/JDV.19229 GOOGLE SCHOLAR lock_openOpen Access editor